Published in J Surg Res on May 03, 2009
Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements. Neoplasia (2012) 1.03
Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity. Front Oncol (2012) 0.87
Integrin β1 is critical for gastrin-releasing peptide receptor-mediated neuroblastoma cell migration and invasion. Surgery (2013) 0.84
Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment. Expert Opin Ther Targets (2016) 0.79
Gastrin-releasing peptide links stressor to cancer progression. J Cancer Res Clin Oncol (2010) 0.78
The breast cancer susceptibility gene product (γ-synuclein) alters cell behavior through it interaction with phospholipase Cβ. Cell Signal (2015) 0.77
Hypoxia regulates the expression of the neuromedin B receptor through a mechanism dependent on hypoxia-inducible factor-1α. PLoS One (2013) 0.76
Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cells. Mol Clin Oncol (2012) 0.76
How gastrin-releasing peptide receptor (GRPR) and αvβ3 integrin expression reflect reorganization features of tumors after hyperthermia treatments. Sci Rep (2017) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature (2000) 7.03
Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism. Cancer Res (1999) 1.98
MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor. Breast Cancer Res Treat (2006) 1.73
Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol (1987) 1.72
IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene (2003) 1.72
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol (2001) 1.51
Gastrin-releasing peptide and cancer. Biochim Biophys Acta (2006) 1.42
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol (2007) 1.28
Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res (2003) 1.27
Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am J Pathol (1999) 1.15
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest New Drugs (2006) 1.15
Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification. Breast Cancer Res (2000) 1.15
Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem (2001) 1.10
Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase. Oncogene (2006) 1.08
Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells. Oncogene (2006) 1.06
Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res (1992) 1.03
The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers. Regul Pept (2000) 0.99
Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095. Eur J Cancer (1998) 0.95
Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells. Int J Cancer (1990) 0.94
Synergistic effects of bombesin and epidermal growth factor on cancers. Proc Natl Acad Sci U S A (1994) 0.94
Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins. Endocr Relat Cancer (2005) 0.88
Fast cancer uptake of 99mTc-labelled bombesin (99mTc BN1). In Vivo (2005) 0.80
Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status. Anticancer Res (1999) 0.80
Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin. Prostate (2003) 0.79
Association between cholecystectomy with vs without intraoperative cholangiography and risk of common duct injury. JAMA (2013) 3.52
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat Cell Biol (2004) 2.59
Surgical privileging and credentialing: a report of a discussion and study group of the American Surgical Association. J Am Coll Surg (2009) 2.18
Clock gene expression in the murine gastrointestinal tract: endogenous rhythmicity and effects of a feeding regimen. Gastroenterology (2007) 1.93
Outcomes following pancreatic resection: variability among high-volume providers. Surgery (2008) 1.73
Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci U S A (2013) 1.69
672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma. Surgery (2008) 1.67
Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg (2009) 1.66
Current management of gastrointestinal carcinoid tumors. J Gastrointest Surg (2004) 1.49
Overuse of CT in patients with complicated gallstone disease. J Am Coll Surg (2011) 1.48
Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg (2006) 1.41
Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann Surg (2002) 1.38
Trends and disparities in regionalization of pancreatic resection. J Gastrointest Surg (2007) 1.35
VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis. Int J Cancer (2011) 1.27
Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res (2003) 1.27
Failure to perform cholecystectomy for acute cholecystitis in elderly patients is associated with increased morbidity, mortality, and cost. J Am Coll Surg (2010) 1.27
Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells. J Biol Chem (2002) 1.24
Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology (2002) 1.15
Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. J Am Coll Surg (2007) 1.12
Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. J Biol Chem (2002) 1.11
Cyclic adenosine 5'-monophosphate-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and protein kinase A signaling pathways. Mol Endocrinol (2006) 1.10
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Br J Pharmacol (2014) 1.10
Gallstone pancreatitis in older patients: Are we operating enough? Surgery (2011) 1.06
The role of protein kinase D in neurotensin secretion mediated by protein kinase C-alpha/-delta and Rho/Rho kinase. J Biol Chem (2004) 1.04
Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues. Endocr Rev (2003) 1.04
Preoperative laboratory testing in patients undergoing elective, low-risk ambulatory surgery. Ann Surg (2012) 1.03
PKD3 is the predominant protein kinase D isoform in mouse exocrine pancreas and promotes hormone-induced amylase secretion. J Biol Chem (2008) 1.02
PKD1, PKD2, and their substrate Kidins220 regulate neurotensin secretion in the BON human endocrine cell line. J Biol Chem (2007) 1.01
Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors. Carcinogenesis (2013) 1.01
Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors. Clin Cancer Res (2014) 0.99
Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Surgery (2002) 0.99
Implementation of a critical pathway for complicated gallstone disease: translation of population-based data into clinical practice. J Am Coll Surg (2011) 0.99
Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin. Eur J Nucl Med Mol Imaging (2007) 0.98
Variation in the use of intraoperative cholangiography during cholecystectomy. J Am Coll Surg (2012) 0.98
Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathway. J Biol Chem (2004) 0.98
CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells. Lab Invest (2011) 0.97
Development and characterization of a novel in vivo model of carcinoid syndrome. Clin Cancer Res (2009) 0.96
mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON. Am J Physiol Cell Physiol (2011) 0.96
Gastrointestinal hormone receptors in primary human colorectal carcinomas. J Surg Res (2005) 0.95
Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology (2003) 0.95
Laser capture microdissection and analysis of amplified antisense RNA from distinct cell populations of the young and aged rat brain: effect of traumatic brain injury on hippocampal gene expression. Brain Res Mol Brain Res (2004) 0.95
Identification of apoptotic genes mediating TGF-beta/Smad3-induced cell death in intestinal epithelial cells using a genomic approach. Am J Physiol Gastrointest Liver Physiol (2006) 0.94
BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation. Am J Physiol Gastrointest Liver Physiol (2013) 0.94
TGF-beta signaling in colon cancer cells. World J Surg (2005) 0.93
Dietary fiber enhances a tumor suppressor signaling pathway in the gut. Ann Surg (2006) 0.91
Overexpression of wild-type PKD2 leads to increased proliferation and invasion of BON endocrine cells. Biochem Biophys Res Commun (2006) 0.91
PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport. Mol Endocrinol (2012) 0.90
Gastrin, inflammation, and carcinogenesis. Curr Opin Endocrinol Diabetes Obes (2010) 0.90
Overexpression and purification of the vanilloid receptor in yeast (Saccharomyces cerevisiae). Biochem Biophys Res Commun (2003) 0.90
TGF-beta inhibits Akt-induced transformation in intestinal epithelial cells. Surgery (2006) 0.90
Influence of stochastic gene expression on the cell survival rheostat after traumatic brain injury. PLoS One (2011) 0.90
Resection benefits older adults with locoregional pancreatic cancer despite greater short-term morbidity and mortality. J Am Geriatr Soc (2011) 0.89
Phorbol ester-mediated neurotensin secretion is dependent on the PKC-alpha and -delta isoforms. Am J Physiol Gastrointest Liver Physiol (2002) 0.89
Traumatic brain injury-induced dysregulation of the circadian clock. PLoS One (2012) 0.89
Molecular correlates of age-specific responses to traumatic brain injury in mice. Exp Gerontol (2006) 0.88
The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa. BMC Physiol (2006) 0.87
Noggin attenuates cerulein-induced acute pancreatitis and impaired autophagy. Pancreas (2013) 0.87
Hypoxia induces mitochondrial DNA damage and stimulates expression of a DNA repair enzyme, the Escherichia coli MutY DNA glycosylase homolog (MYH), in vivo, in the rat brain. J Neurochem (2002) 0.86
Dietary fiber enhances TGF-β signaling and growth inhibition in the gut. Am J Physiol Gastrointest Liver Physiol (2011) 0.85
SRC regulates constitutive internalization and rapid resensitization of a cholecystokinin 2 receptor splice variant. J Biol Chem (2005) 0.84
Traumatic brain injury in vivo and in vitro contributes to cerebral vascular dysfunction through impaired gap junction communication between vascular smooth muscle cells. J Neurotrauma (2014) 0.84
Agonist- and protein kinase C-induced phosphorylation have similar functional consequences for gastrin-releasing peptide receptor signaling via Gq. Mol Pharmacol (2003) 0.84
Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation. Cell Cycle (2013) 0.83
Agonist-independent activation of Src tyrosine kinase by a cholecystokinin-2 (CCK2) receptor splice variant. J Biol Chem (2004) 0.83
Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells. Int J Cancer (2014) 0.82
CCK2 receptor expression transforms non-tumorigenic human NCM356 colonic epithelial cells into tumor forming cells. Int J Cancer (2010) 0.82
Effects of trauma, hemorrhage and resuscitation in aged rats. Brain Res (2012) 0.82
L-Arginine decreases fluid-percussion injury-induced neuronal nitrotyrosine immunoreactivity in rats. J Cereb Blood Flow Metab (2008) 0.82
A proposal for enhancing the general surgical workforce and access to surgical care. Ann Surg (2012) 0.82
The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON. Anticancer Res (2011) 0.81
Crew resource management improved perception of patient safety in the operating room. Am J Med Qual (2009) 0.81
Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins. BMC Cancer (2007) 0.80
Glucocorticoids and polyamine inhibitors synergize to kill human leukemic CEM cells. Neoplasia (2002) 0.80
Cerebrovascular connexin expression: effects of traumatic brain injury. J Neurotrauma (2011) 0.80
Role of parathyroid hormone-related protein in the pro-inflammatory and pro-fibrogenic response associated with acute pancreatitis. Regul Pept (2012) 0.80
Time trends and geographic variation in use of minimally invasive breast biopsy. J Am Coll Surg (2013) 0.80
PTHrP is a novel mediator for TGF-β-induced apoptosis. Regul Pept (2013) 0.80
Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells. BMC Mol Biol (2011) 0.79
The health workforce: a position statement. Ann Surg (2007) 0.79
Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer (2010) 0.79
Dual inhibition of PI3K and mTOR signaling pathways decreases human pancreatic neuroendocrine tumor metastatic progression. Pancreas (2014) 0.79
Effects of hypertonic arginine on cerebral blood flow and intracranial pressure after traumatic brain injury combined with hemorrhagic hypotension. Shock (2006) 0.78
Raf-1 kinase inhibitory protein (RKIP) mediates ethanol-induced sensitization of secretagogue signaling in pancreatic acinar cells. J Biol Chem (2012) 0.78
Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N gene. J Biol Chem (2010) 0.77
Synergistic regulation of COX-2 expression by bombesin and transforming growth factor-beta. Dig Dis Sci (2007) 0.77
Bombesin enhances TGF-beta growth inhibitory effect through apoptosis induction in intestinal epithelial cells. Regul Pept (2009) 0.77